2016-01100. Conditional Approval of a New Animal Drug No Longer in Effect; Masitinib  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect that the conditional approval of an application for masitinib mesylate tablets, a new animal drug for a minor use, is no longer in effect.

    DATES:

    This rule is effective January 21, 2016.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5689, george.haibel@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    FDA is amending the animal drug regulations to reflect that application 141-308 for conditional approval of KINAVET-CA1 (masitinib mesylate) Tablets, a new animal drug for a minor use sponsored by AB Science, 3 Avenue George V, 75008 Paris, France, is no longer in effect.

    Elsewhere in this issue of the Federal Register, FDA gave notice that conditional approval of this drug, by operation of law, was no longer in effect as of December 15, 2015.

    This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

    Start List of Subjects

    List of Subjects

    21 CFR Part 510

    • Administrative practice and procedure
    • Animal drugs
    • Labeling
    • Reporting and recordkeeping requirements

    21 CFR Part 516

    • Administrative practice and procedure
    • Animal drugs
    • Confidential business information
    • Reporting and recordkeeping requirements
    End List of Subjects

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 516 are amended as follows:

    Start Part

    PART 510—NEW ANIMAL DRUGS

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 510 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

    End Authority
    [Amended]
    Start Amendment Part

    2. In § 510.600, in the table in paragraph (c)(1), remove the entry for “AB Science” and in the table in paragraph (c)(2), remove the entry for “052913”.

    End Amendment Part Start Part

    PART 516—NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES

    End Part Start Amendment Part

    3. The authority citation for 21 CFR part 516 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360ccc-1, 360ccc-2, 371.

    End Authority
    [Removed]
    Start Amendment Part

    4. Remove § 516.1318.

    End Amendment Part Start Signature

    Dated: January 14, 2016.

    Bernadette Dunham,

    Director, Center for Veterinary Medicine.

    End Signature End Supplemental Information

    [FR Doc. 2016-01100 Filed 1-20-16; 8:45 am]

    BILLING CODE 4164-01-P